NCT00561769
Completed
Not Applicable
Growth Hormone co-Treatment Within a GnRH Agonist Long Protocol in Patients With Poor Ovarian Response
Gulhane School of Medicine1 site in 1 country61 target enrollmentJanuary 2005
Overview
- Phase
- Not Applicable
- Intervention
- Norditropin pen
- Conditions
- Infertility
- Sponsor
- Gulhane School of Medicine
- Enrollment
- 61
- Locations
- 1
- Primary Endpoint
- mature oocyte number
- Status
- Completed
- Last Updated
- 18 years ago
Overview
Brief Summary
Commencing of growth hormone in luteal phase when follicular cohort for the next cycle is being gathered may increase mature oocytes in poor responder
Investigators
Eligibility Criteria
Inclusion Criteria
- •Poor responder
Exclusion Criteria
- •FSH \>20 IU
Arms & Interventions
A
poor responder
Intervention: Norditropin pen
Outcomes
Primary Outcomes
mature oocyte number
Time Frame: 2 years
Secondary Outcomes
- pregnancy rate(2 years)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)InfertilityPoor Ovarian ReserveNCT01204840Ottawa Fertility Centre38
Unknown
Phase 2
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian ResponseInfertility, FemaleNCT03373149Riyadh Fertility and Reproductive Health center228
Terminated
Phase 4
Growth Hormone and GnRH Agonist in Adolescents With Acquired HypothyroidismHypothyroidismNCT00206375Baylor College of Medicine16
Unknown
Phase 1
Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer CyclesGnRHa;LPSNCT02908438Northwest Women's and Children's Hospital, Xi'an, Shaanxi400
Completed
Phase 4
Early Follicular Supplementation of Ganirelix in IVF 2004InfertilityIVF TreatmentNCT00461422The Baruch Padeh Medical Center, Poriya50